Form D — NK-One Therapeutics, Inc.
0002127553-26-000001 · filed 2026-04-27
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $310,000
- Total sold
- $290,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NK-One Therapeutics, Inc.
- CIK
- 2127553
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 526 PARK RIDGE DRIVE
WAYNE, PA 19087 - Phone
- 610-733-0446
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Shine · Executive OfficerWayne, PA Find on LinkedIn ↗
-
Marco Pappagallo · Executive OfficerWayne, PA Find on LinkedIn ↗
View original on SEC EDGAR.